MiR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2

Overview

Journal Oncol Res

Specialty Oncology

Date 2018 Feb 24

PMID 29471894

Citations 7

Authors

Fengyu Huang

Hongjun Zhao

Zhaojin Du

Hong Jiang

Affiliations

Soon will be listed here.

Abstract

Previous studies have reported that miR-615 exerts a tumor suppressor role in some tumors, such as esophageal squamous cell carcinoma and non-small cell lung cancer. However, the role of miR-615 in prostate cancer has not been defined. Here we found that miR-615 was downregulated in prostate cancer tissues and cell lines. Overexpression of miR-615 in PC-3 cells significantly inhibited cellular proliferation, migration, and invasion. Moreover, overexpression of miR-615 delayed tumor growth in vivo. In terms of mechanism, we found that cyclin D2 (CCND2) is a target gene of miR-615 in prostate cancer. We showed that miR-615 could bind to the 3'-UTR region of CCND2 mRNA and inhibit its expression. There was a negative correlation between the expression of miR-615 and CCND2 in prostate cancer tissues. Moreover, restoration of cyclin D2 abolished the inhibitory effects of miR-615 on the proliferation, migration, and invasion of prostate cancer cells. Taken together, our study identified miR-615 as a tumor suppressor by targeting cyclin D2 in prostate cancer.

Citing Articles

Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer.

Lin F, Long Y, Li M, Cai C, Wu Y, You X Heliyon. 2024; 10(12):e32914.

PMID: 38994113 PMC: 11237975. DOI: 10.1016/j.heliyon.2024.e32914.

Integrated co-expression analysis of regulatory elements (miRNA, lncRNA, and TFs) in bovine monocytes induced by Str. uberis.

Sharifi S, Pakdel A, Pakdel M, Tabashiri R, Bakhtiarizadeh M, Tahmasebi A Sci Rep. 2023; 13(1):15076.

PMID: 37699972 PMC: 10497586. DOI: 10.1038/s41598-023-42067-4.

Iodine-125 seed represses the growth and facilitates the apoptosis of colorectal cancer cells by suppressing the methylation of miR-615 promoter.

Ren F, Li B, Wang C, Wang Y, Cui B BMC Cancer. 2022; 22(1):49.

PMID: 34998382 PMC: 8742920. DOI: 10.1186/s12885-021-09141-4.

MicroRNA-615-5p regulates the proliferation and apoptosis of breast cancer cells by targeting HSF1.

Liu K, Ma R Exp Ther Med. 2021; 21(3):192.

PMID: 33488801 PMC: 7812586. DOI: 10.3892/etm.2021.9624.

MicroRNA-615 functions as a tumor suppressor in osteosarcoma through the suppression of HK2.

Sun L, Wang P, Zhang Z, Zhang K, Xu Z, Li S Oncol Lett. 2020; 20(5):226.

PMID: 32968448 PMC: 7500052. DOI: 10.3892/ol.2020.12089.

References

Bai Y, Li J, Li J, Liu Y, Zhang B . MiR-615 inhibited cell proliferation and cell cycle of human breast cancer cells by suppressing of AKT2 expression. Int J Clin Exp Med. 2015; 8(3):3801-8. PMC: 4443111. View

Dong Q, Meng P, Wang T, Qin W, Qin W, Wang F . MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One. 2010; 5(4):e10147. PMC: 2854685. DOI: 10.1371/journal.pone.0010147. View

Denli A, Tops B, Plasterk R, Ketting R, Hannon G . Processing of primary microRNAs by the Microprocessor complex. Nature. 2004; 432(7014):231-5. DOI: 10.1038/nature03049. View

El Tayebi H, Hosny K, Esmat G, Breuhahn K, Abdelaziz A . miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. FEBS Lett. 2012; 586(19):3309-16. DOI: 10.1016/j.febslet.2012.06.054. View

Yu J, Xia S . Novel role of microRNAs in prostate cancer. Chin Med J (Engl). 2013; 126(15):2960-4. View

Zhu C, Shao P, Bao M, Li P, Zhou H, Cai H . miR-154 inhibits prostate cancer cell proliferation by targeting CCND2. Urol Oncol. 2013; 32(1):31.e9-16. DOI: 10.1016/j.urolonc.2012.11.013. View

Cetin K, Beebe-Dimmer J, Fryzek J, Markus R, Carducci M . Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology. 2009; 75(6):1396-404. PMC: 4249683. DOI: 10.1016/j.urology.2009.07.1360. View

Silvestri I, Cattarino S, Agliano A, Collalti G, Sciarra A . Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer. Biomed Res Int. 2015; 2015:794968. PMC: 4486485. DOI: 10.1155/2015/794968. View

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

10.

Miska E . How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005; 15(5):563-8. DOI: 10.1016/j.gde.2005.08.005. View

11.

Liu Y, Xu X, Xu X, Li S, Liang Z, Hu Z . MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1. Oncol Lett. 2017; 14(5):5121-5128. PMC: 5666665. DOI: 10.3892/ol.2017.6865. View

12.

Nazim S, Abbas F . Role of Surgery in locally advanced prostate cancer. Pak J Med Sci. 2015; 31(3):710-6. PMC: 4485300. DOI: 10.12669/pjms.313.7103. View

13.

Pu H, Xu R, Zhang M, Yuan L, Hu J, Huang G . Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancer. Oncol Lett. 2017; 13(4):2403-2410. PMC: 5403291. DOI: 10.3892/ol.2017.5684. View

14.

Winter J, Jung S, Keller S, Gregory R, Diederichs S . Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11(3):228-34. DOI: 10.1038/ncb0309-228. View

15.

Guo J, Xiao Z, Yu X, Cao R . miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer. Oncol Lett. 2017; 14(6):6895-6900. PMC: 5691384. DOI: 10.3892/ol.2017.7041. View

16.

Zheng H, Wu J, Shi J, Lu C, Wang Y, Sun Q . miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9. Oncol Rep. 2017; 38(3):1790-1796. DOI: 10.3892/or.2017.5812. View

17.

Yang B, Xie R, Wu S, Gao C, Yang X, Zhou J . MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma. Oncol Rep. 2017; 39(1):255-263. DOI: 10.3892/or.2017.6079. View

18.

Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D . Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol. 2012; 41(6):1897-912. DOI: 10.3892/ijo.2012.1647. View

19.

Huang C, Huang J, Ma P, Yu G . microRNA-143 acts as a suppressor of hemangioma growth by targeting Bcl-2. Gene. 2017; 628:211-217. DOI: 10.1016/j.gene.2017.07.046. View

20.

Tay F, Lim J, Zhu H, Hin L, Wang S . Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells. Adv Drug Deliv Rev. 2014; 81:117-27. DOI: 10.1016/j.addr.2014.05.010. View